Your session is about to expire
← Back to Search
OrthoK Lenses for Myopia Progression
Study Summary
This trial is investigating whether orthokeratology (ortho-k) lenses, which are worn at night and change the corneal topography to correct low to moderate amounts of myopia, can also help slow axial elongation (which leads to degenerative changes like retinal detachment, glaucoma, and vitreal degeneration) in young adults.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have followed all treatment instructions without the expected improvement.I have had eye surgery or an eye injury in the past.I am in good health with no conditions affecting my eyes or vision.I can attend all required clinic visits for follow-up care.
- Group 1: Control
- Group 2: OrthoK
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the eligibility requirements to participate in this trial?
"Candidates aged between 20 and 40, who have experienced disease progression, can qualify for this trial. In total, 80 individuals are expected to be enrolled."
How perilous is OrthoK for individuals?
"Based on our research at Power, OrthoK was given a rating of 2 since the intervention is in Phase 2. This implies there has been some evidence demonstrating its safety profile but no data confirming efficacy."
Are there still opportunities for individuals to participate in this research?
"The given clinical trial does not appear to be currently enrolling patients, as the last update was made on December 3rd 2015. Despite this, there are still 74 other trials that require volunteers at this time."
Is the age criterion for this experiment restricted to individuals over 25 years of age?
"Per the requirements of this clinical trial, potential participants must range between 20 and 40 years old."
Share this study with friends
Copy Link
Messenger